BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23067304)

  • 1. A cross-validation of the provisional diagnostic instrument (PDI-4).
    Faries DE; Houston JP; Sulcs EM; Swindle RW
    BMC Fam Pract; 2012 Oct; 13():104. PubMed ID: 23067304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A provisional screening instrument for four common mental disorders in adult primary care patients.
    Houston JP; Kroenke K; Faries DE; Doebbeling CC; Adler LA; Ahl J; Swindle R; Trzepacz PT
    Psychosomatics; 2011; 52(1):48-55. PubMed ID: 21300195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDI-4A: an augmented provisional screening instrument assessing 5 additional common anxiety-related diagnoses in adult primary care patients.
    Houston JP; Kroenke K; Davidson JR; Adler LA; Faries DE; Ahl J; Swindle R; Trzepacz PT
    Postgrad Med; 2011 Sep; 123(5):89-95. PubMed ID: 21904090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
    Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
    J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of clinical symptom IRT scores for diagnosis and severity assessment of common mental disorders.
    Olariu E; Castro-Rodriguez JI; Álvarez P; Garnier C; Reinoso M; Martín-López LM; Alonso J; Forero CG
    Qual Life Res; 2015 Apr; 24(4):979-92. PubMed ID: 25281010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinically useful self-report measure of the DSM-5 mixed features specifier of major depressive disorder.
    Zimmerman M; Chelminski I; Young D; Dalrymple K; Martinez JH
    J Affect Disord; 2014 Oct; 168():357-62. PubMed ID: 25103631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of the Associated Symptom Criteria for Generalized Anxiety Disorder: Observations From the Singapore Mental Health Study.
    Lee SP; Ong C; Vaingankar JA; Chong SA; Subramaniam M
    J Nerv Ment Dis; 2017 May; 205(5):390-396. PubMed ID: 27805985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hospital Anxiety and Depression Rating Scale: a cross-sectional study of psychometrics and case finding abilities in general practice.
    Olssøn I; Mykletun A; Dahl AA
    BMC Psychiatry; 2005 Dec; 5():46. PubMed ID: 16351733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Child mania rating scale: development, reliability, and validity.
    Pavuluri MN; Henry DB; Devineni B; Carbray JA; Birmaher B
    J Am Acad Child Adolesc Psychiatry; 2006 May; 45(5):550-560. PubMed ID: 16601399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge and Behavior of Primary Care Physicians Regarding Utilization of Standardized Tools in Screening and Assessment of Anxiety, Depression, and Mood Disorders at a Large Integrated Health System.
    Waheed A; Afridi AK; Rana M; Arif M; Barrera T; Patel F; Khan MN; Azhar E
    J Prim Care Community Health; 2024; 15():21501319231224711. PubMed ID: 38327064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation and initial validation of the Patient Health Questionnaire - 9 (PHQ-9) and the Generalized Anxiety Disorder - 7 Questionnaire (GAD-7) in an Arabic speaking Lebanese psychiatric outpatient sample.
    Sawaya H; Atoui M; Hamadeh A; Zeinoun P; Nahas Z
    Psychiatry Res; 2016 May; 239():245-52. PubMed ID: 27031595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinician-rated versus self-rated screening for bipolar disorder among inpatients with mood symptoms and substance misuse.
    Goldberg JF; Garakani A; Ackerman SH
    J Clin Psychiatry; 2012 Dec; 73(12):1525-30. PubMed ID: 23290325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. German validation of the Conners Adult ADHD Rating Scales (CAARS) II: reliability, validity, diagnostic sensitivity and specificity.
    Christiansen H; Kis B; Hirsch O; Matthies S; Hebebrand J; Uekermann J; Abdel-Hamid M; Kraemer M; Wiltfang J; Graf E; Colla M; Sobanski E; Alm B; Rösler M; Jacob C; Jans T; Huss M; Schimmelmann BG; Philipsen A
    Eur Psychiatry; 2012 Jul; 27(5):321-8. PubMed ID: 21392946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting depressive and anxiety disorders in distressed patients in primary care; comparative diagnostic accuracy of the Four-Dimensional Symptom Questionnaire (4DSQ) and the Hospital Anxiety and Depression Scale (HADS).
    Terluin B; Brouwers EP; van Marwijk HW; Verhaak P; van der Horst HE
    BMC Fam Pract; 2009 Aug; 10():58. PubMed ID: 19698153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of the combined application of the Mood Disorder Questionnaire and Bipolar Spectrum Diagnostic Scale in screening for bipolar disorder.
    Lee D; Cha B; Park CS; Kim BJ; Lee CS; Lee S
    Compr Psychiatry; 2013 May; 54(4):334-40. PubMed ID: 23151598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships Between Functional Outcomes and Symptomatic Improvement in Atomoxetine-Treated Adult Patients with Attention-Deficit/Hyperactivity Disorder: Post Hoc Analysis of an Integrated Database.
    De Bruyckere K; Bushe C; Bartel C; Berggren L; Kan CC; Dittmann RW
    CNS Drugs; 2016 Jun; 30(6):541-58. PubMed ID: 27224994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Informative Are Self-Reported Adult Attention-Deficit/Hyperactivity Disorder Symptoms? An Examination of the Agreement Between the Adult Attention-Deficit/Hyperactivity Disorder Self-Report Scale V1.1 and Adult Attention-Deficit/Hyperactivity Disorder Investigator Symptom Rating Scale.
    Silverstein MJ; Faraone SV; Alperin S; Biederman J; Spencer TJ; Adler LA
    J Child Adolesc Psychopharmacol; 2018 Jun; 28(5):339-349. PubMed ID: 29172673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and diagnostic validity of the M-3 checklist: a brief, self-rated screen for depressive, bipolar, anxiety, and post-traumatic stress disorders in primary care.
    Gaynes BN; DeVeaugh-Geiss J; Weir S; Gu H; MacPherson C; Schulberg HC; Culpepper L; Rubinow DR
    Ann Fam Med; 2010; 8(2):160-9. PubMed ID: 20212303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between attention deficit hyperactivity disorder, bipolarity and mixed features in major depressive patients: Evidence from the BRIDGE-II-Mix Study.
    Vannucchi G; Medda P; Pallucchini A; Bertelli M; Angst J; Azorin JM; Bowden C; Vieta E; Young AH; Mosolov S; Perugi G;
    J Affect Disord; 2019 Mar; 246():346-354. PubMed ID: 30597295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does presence of metabolic syndrome impact anxiety and depressive disorder screening results in middle aged and elderly individuals? A population based study.
    Butnoriene J; Steibliene V; Saudargiene A; Bunevicius A
    BMC Psychiatry; 2018 Jan; 18(1):5. PubMed ID: 29310620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.